Licence alone makes it a 100M mcap. I trust you understand why it's the case. There are specific things I've detailed in other posts that increases AEB's value. This is my fair value for 2018 for AEB,
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
OAR Chris Judd's Talk Ya Book: Orthocell building on 'enormous potential' with steady growth - and US push to come